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Toxin-antitoxin (TA)modules contribute to the generation of non-growing cells in response to stress. These
modules abound in bacterial pathogens although the bases for this profusion remain largely unknown.
Using the intracellular bacterial pathogen Salmonella enterica serovar Typhimurium as a model, here we
show that a selected group of TAmodules impact bacterial fitness inside eukaryotic cells. We characterized
in this pathogen twenty-seven TA modules, including type I and type II TA modules encoding antisense
RNA and proteinaceous antitoxins, respectively. Proteomic and gene expression analyses revealed that the
pathogen produces numerous toxins of TAmodules inside eukaryotic cells. Among these, the toxins HokST,
LdrAST, and TisBST, encoded by type I TAmodules and T4ST and VapC2ST, encoded by type II TAmodules,
promote bacterial survival inside fibroblasts. In contrast, only VapC2ST shows that positive effect in
bacterial fitness when the pathogen infects epithelial cells. These results illustrate how S. Typhimurium uses
distinct type I and type II TA modules to regulate its intracellular lifestyle in varied host cell types. This
function specialization might explain why the number of TA modules increased in intracellular bacterial
pathogens.
T
oxin-antitoxinmodules (hereafter TA) were discovered in bacteria due to their capacity to stabilize plasmids
by interfering with the viability of plasmid-free segregants1–3. This phenomenon results from differential
stability of the toxin (stable) and the antitoxin (unstable). TAmodules are composed of two small genes and
classified in five types attending to the antitoxin nature and its mode of action. Antitoxins are either small RNAs
(type I and III modules) or proteins (type II, IV and V modules). All known toxins are proteins and exhibit
activities ranging from RNAses to DNA gyrase inhibitors4–6. TA loci abound in microbial genomes7–10 and are
found in archaea11 and, in free-living, symbiotic and obligate intracellular bacteria4,5.
Toxins encoded by TA modules trigger mainly bacteriostatic effects12–14. These toxins are implicated in
processes as phage abortive infection15,16; survival in response to nutrient starvation17–20 or to oxidative
damage21,22; biofilm formation23–25; and, tolerance to antimicrobial drugs14,26. Growth arrest caused by TA mod-
ules leads to selection of persisters, which are rare slow-growing or dormant cells that normally exist in popula-
tions of actively growing cells14,26. This selection occurs stochastically with no associated heritable genetic
alteration.
TA modules have been mostly characterized in bacteria growing in axenic cultures14,26,27. In addition, recent
studies implicate TAmodules in virulence. Thus, uropathogenic Escherichia coli andHaemophilus influenzae use
type II TAmodules to colonize and survive in animal organs28–30.Mycobacterium tuberculosis up-regulates genes
encoding type II TA modules inside macrophages8. A type II TA module termed sehAB, homolog of the higBA/
relBE type II TAmodule, is required for survival of Salmonella enterica serovar Typhimurium (S. Typhimurium)
in mice31. Due to the capacity of TA modules to arrest bacterial growth, recent studies have focused in under-
standing whether TA modules contribute to formation of dormant cells in chronic and persistent infections32.
Bacterial pathogens that cause these types of infections contain more TA modules than non-pathogenic species
that are related phylogenetically8,33,34. Using a macrophage infection model, a recent study reported impaired
generation of non-growing S. Typhimurium cells in mutants lacking each of the 14 type II TAmodules that were
tested32. An equal contribution of such a large number of TAmodules to arrest bacterial growth during infection
is, however, intriguing.
OPEN
SUBJECT AREAS:
CELLULAR
MICROBIOLOGY
MOLECULAR BIOLOGY
Received
13 December 2014
Accepted
2 March 2015
Published
20 March 2015
Correspondence and
requests for materials
should be addressed to
R. D.-O.(ramondiaz@
cib.csic.es) or F.G.P.
(fgportillo@cnb.csic.es)
SCIENTIFIC REPORTS | 5 : 9374 | DOI: 10.1038/srep09374 1
S. enterica is an intracellular bacterial pathogen associated to per-
sistent infections in humans and livestock35. The serovar Typhi-
murium has been extensively studied in murine models in which
the pathogen causes either acute36 or chronic infections37,38. In the
animal, S. Typhimurium shows limited proliferation inside macro-
phages39. This pathogen also attenuates growth in cultured fibro-
blasts40 and in non-phagocytic cells of the intestinal lamina
propria41. The study reported here includes a comprehensive analysis
of S. Typhimurium TA modules and shows that a selected group of
toxins encoded by these modules might have evolved to control
bacterial survival inside host cells. Besides this specialization of func-
tions, our data also implicate for the first time toxins encoded by type
I TA modules in promoting pathogen survival in the infected eukar-
yotic cell.
Results
S. Typhimurium has a large number of TAmodules.Our first aim
was to identify every putative TA module in the genome of the S.
Typhimurium virulent strain SL1344 (http://www.ncbi.nlm.nih.gov/
genome/152?genome_assembly_id523044). We used the database
described by Fozo et al.7 and the web resource TADB (http://bioinfo-
mml.sjtu.edu.cn/TADB/)9 to search for type I and type II TA
modules, respectively. Twenty-four TA loci, accounting for five
type I and 19 type II TA modules, were identified (Fig. 1a, Table 1,
Supplementary Table S1). Other available tools that predict type II
TA modules such as RASTA (http://genoweb1.irisa.fr/duals/
RASTA-Bacteria/) did not identify additional hits. PSI-BLAST was
also carried out using as queries validated toxins and antitoxins
described for TA modules of distinct types (Supplementary Table
S2). This PSI-BLAST identified three new putative TA modules, two
type I loci (hok-sokST and symERST) and one type II locus (pasTIST)
(Fig. 1a, Table 1, Supplementary Table S1). Recent massive analyses
performed for type II10 and type III42 TA modules were also
examined although no new hit was found in the SL1344 genome.
To keep consistently with previous TA nomenclature, we assigned
original names to those TAmodules displaying high sequence homo-
logy to those previously characterized at the functional level in S.
Typhimurium and other bacteria (e.g. ccdABST, phd-docST, vapBCST,
relBEST, shpABST). Strikingly, most of the genes we identified as
encoding putative type I TA modules were not annotated as genes
in the S. Typhimurium SL1344 genome. This lack of annotation
might be related to the marked small size of the toxin and antitoxin
genes. Module size ranges from ,50 to ,150 nucleotides in length
for the five type I TAmodules identified in our study, which are listed
in Table 1 with their respective genome coordinates. We also
assigned original names to those proteins carrying functional
domains of known toxins but not displaying high amino acid
sequence similarity with described TA modules. This was the case
of proteins encoded by the relBE3ST, relBE4ST and higBAST loci
(Supplementary Table S1). In the case of the type II TA modules
Figure 1 | TA modules identified in S. Typhimurium strain SL1344. (a) Workflow depicting the in silico analyses that led to the identification of 27
putative TA modules in S. Typhimurium strain SL1344. The study of Fozo et al.7 is focused in type I modules whereas that of Shao et al.9 describes the
TADB web resource that compiles type II modules from different organisms; (b) distribution of the 27 TA loci identified encoding seven type I (orange)
and 20 type II (red)modules in the chromosome and plasmids of strain SL1344; (c) conservation of the 27 TA loci identified in S.Typhimurium SL1344 in
the genome of other Salmonella species and S. enterica serovars. Homolog search was performed using the tBLASTn tool and as query the protein
sequences of toxins and antitoxins identified in S. Typhimurium SL1344. The results of this search were contrasted with recent data reported by Nuccio
and Baumler44, which compared genome sequences of S. enterica serovars causing gastrointestinal and extraintestinal pathologies. Abbreviations: STm-
SL1344, S. Typhimurium SL1344; STm-LT2, S. Typhimurium LT2; SNew, S. Newport SL254; SHei, S. Heildeberg SL476; SSch, S. Schwarzengrund
CVM19633; SAgo, S.Agona SL483; SEnt, S. Enteritidis P125109; SPB, S. Paratyphi B SP87; STy1; S.Typhi CT18; STy2; S.Typhi Ty2; SPA1, S. Paratyphi A
ATCC9150; SPA2, S. Paratyphi A AKU_12601; SDub, S. Dublin CT_02021853; SGal, S. Gallinarum 287/91; SCho, S. Choleraesuis SC-B67; SPC,
S. Paratyphi C RKS4594; S. bongori-1, strain N268-08; S. bongori-2, strain NCTC12419. Colour code: green, both T and A homologs identified; blue, only
T homolog identified; yellow: only A homolog identified; black, no homolog identified. Only hits with e-values # 1025 and pairing encompassing a
minimum of 30 amino acids were considered significant.
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named sehABST and sehCDST by De la Cruz et al.31, we maintained
that terminology although they are highly homologous to the higBA/
relBE modules. Lastly, those unknown TA modules for which we
found no homologs in the literature or in databases were referred
as ‘‘TA-(number)-ST’’, denoting their first identification in S.
Typhimurium. We also provide the exact genome coordinates for
these novel type II TA modules. Tables 1 and Supplementary Table
S1 depict the complete list of TAmodules identified in our study and
their relevant features.
Most of the 27 TA modules predicted in S. Typhimurium strain
SL1344 have a chromosomal location (Fig. 1b). Four of the 27 TA loci
map in two of the three plasmids that the strain SL1344 bears. A
vapBCST paralog (here referred as vapBC2ST) and a ccdABST homolog
map in the pSLT virulence plasmid whereas hok-sokST and relBE4ST
locate in the pCol1B9 plasmid (Table 1, Fig. 1b). Altogether, these
data showed an unsuspected large repertoire of putative TA loci in S.
Typhimurium, about double of those reported for this pathogen in
recent studies31,32. This large number of TA modules led us to hypo-
thesize about distinct TAmodules that could contribute to the fitness
of the pathogen inside eukaryotic cells.
Acquisition of TA modules has been favoured in pathogenic
Salmonella species. The genus Salmonella is composed by the
pathogenic species S. enterica and the non-pathogenic species S.
bongori43. We reasoned that some of the TA modules, if specialised
for contributing to the fitness of intracellular bacteria, might show
a narrow distribution restricted to pathogenic bacteria. This
specialization of TA modules could also occur among to S. enterica
serovars associated to gastrointestinal or systemic diseases. To test
this, we used as reference the recent study by Nuccio and Baumler44,
who compared gene content in S. enterica serovars that cause either
gastrointestinal or systemic pathologies in human and livestock.
Those genes encoding TA modules not included in that genome
comparative study were used as query in NCBI databases using
tBLASTn. Strikingly, up to 17 of the 27 TA loci identified in S.
Typhimurium SL1344 are absent in the two strains of the non-
pathogenic species S. bongori with genome sequence available
(Fig. 1c). Another prominent feature is the presence of some TA
modules in all S. enterica serovars whereas other TA modules
display a narrow distribution in only a few serovars. This is the
case of the chromosomal type I TA module ibsA-sibAST, restricted
to serovar Typhimurium (Fig. 1c); or, ibsB-sibBST, which is present in
serovars Typhimurium, Newport, Agona, Typhi, Paratyphi A,
Paratyphi B, Paratyphi C and Choleraesuis (Fig. 1c). No TA
module was found to be restricted to serovars associated to either
gastrointestinal or systemic infections (Fig. 1c). Distribution of the
plasmid-encoded TA modules ccdABST, vapBC2ST, hok-sokST and
relBE4ST was limited to S. Typhimurium and other serovars
causing system infections such as S. Choleraesuis and S. Paratyphi
C (Fig. 1c). Taken together, these data suggest that acquisition of TA
modules might have been favoured in S. enterica respect the non-
pathogenic species S. bongori. Some of these TA modules might also
have evolved differently among pathogenic S. enterica serovars. This
scenario is reminiscent to that reported for other bacterial pathogens
as Mycobacterium tuberculosis, which has more TA modules than
environmental non-pathogenic mycobacteria34.
The TA loci identified in S. Typhimurium encode multiple toxins
with anti-proliferative activity. Anti-proliferative and neutralizing
activities were next tested for predicted toxins and antitoxins,
respectively. Genes encoding toxins and antitoxins of type II TA
modules and toxins of type I TA modules were cloned in
compatible expression vectors suitable to control expression of
each component independently (see Methods). These functional
assays were performed in the natural host, S. Typhimurium strain
SL1344. Thirteen out of the 20 type II TA modules predicted in the
genome of strain SL1344 behaved as bona fide TAmodules (Fig. 2a).
Thus, toxins encoded by these thirteen type II TA modules decrease
bacterial cultivability, which is restored upon antitoxin co-
expression (Fig. 2a). Tests in the putative type I TA modules
showed that five of the seven predicted toxins, HokST, IbsAST,
LdrAST, LdrBST, TisBST, impact negatively bacterial growth
(Fig. 2b). To our knowledge, these assays are the first
demonstrating anti-proliferative activity for some novel toxins
predicted here for the fist time and for others previously annotated
as putative toxins. These novel and validated toxins include T1ST,
T2ST, T4ST, T5ST, RelE3ST, RelE4ST, HokST, IbsAST, LdrAST, LdrBST
and TisBST (Table 1, Fig. 2a, 2b). Of interest, some toxins of the type
II modules that behave functional in our assays were not as such in
previous studies with S.Typhimurium grown in liquid culture31. This
is the case of RelEST, RelE2ST, RelE3ST, SehABST, SehCDST, and
VapC2ST (Table 1, Fig. 2a). We also found type II TA modules that
did not obey the toxicity-neutralization rule, differentiating two
groups: i) antitoxins that do not neutralize their cognate toxins,
e.g. A1ST and RelB3ST (Fig. 2a); and, ii) toxins that do not have
clear effects in cultivability as T3ST, HigBST, CcdBST, PasTST,
VapCST, IbsBST, and SymEST (Fig. 2a). Three independent cloning
experiments led to identical results. Production of these ‘non-
functional’ toxins following inducer addition was confirmed by
either Commassie staining or Western blotting (Supplementary
Fig. S1). A lack of function that brought our attention was that of
CcdBST, one of the two type II TA systems that strain SL1344 bears in
the virulence pSLT plasmid (Table 1, Fig 1b).When compared to the
CcdB of E. coli plasmid F, we noticed an R99W amino acid
substitution in the S. Typhimurium CcdBST homolog. Residue R99
Table 1 | TA loci identified in the genome of S. Typhimurium strain
SL1344
TA locus (*)
TA module
type
Coordinates/
gene ID ({)
Identification
method/Reference
hok-sokST ({) I 41921–42073 PSI-BLAST
ldrB-rdlBST I 466721–466936 7
ibsB-sibBST I 2211602–2211658 7
ibsA-sibAST I 3383044–3383103 7
ldrA-rdlAST I 3829510–3829724 7
tisB-istRST I 4019333–4019842 7
symERST I SL4454 (symEST) PSI-BLAST
relBEST II SL1480 – SL1479 9
ta1ST II SL2380 - SL2379 9
pasTIST II SL2659 - SL2658 PSI-BLAST
ta2ST II SL2885 - SL2884 9
parDEST II SL2935 - SL2936 9
vapBCST II SL3012 - SL3011 9
ta3ST II SL3437 - SL3438 9
dinJ-yafQST II SL3484 - SL3483 9
phd-docST II SL3525 - SL3524 9
ta4ST II SL3618 - SL3617 9
relBE3ST II SL3744 - SL3743 9
higBAST II SL3866 - SL3867 9
sehABST II SL3976 - SL3977 9
sehCDST II SL3979 - SL3980 9
ta5ST II SL4254 - SL4253 9
relBE2ST II SL4379 - SL4380 9
shpABST II SL4459 - SL4460 9
ccdABST ({) II PSLT027 - PSLT028 9
vapBC2ST ({) II PSLT107 - PSLT106 9
relBE4ST ({) II SLP2_0004 - SLP2_0003 9
(*) Subscript ST is added for clarification purposes to refer exclusively to TA modules characterized
functionally in S. Typhimurium in this study.
({) Coordinates and gene ID of S. Typhimurium strain SL1344 based on annotations and
sequences deposited in NCBI with entries NC_016810.1 (chromosome), NC_017720.1
(plasmid 1, pSLT), and NC_017718.1 (plasmid 2, pCol1B9). Toxin-encoding genes are
underlined.
({) TA loci mapping in plasmids.
www.nature.com/scientificreports
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is reported to be crucial for toxicity in E. coli45 and an artificial
reversion of the R99W mutation in S. Typhimurium restores toxin
functionality (Supplementary Fig. S2a). Similarly, PasTST of S.
Typhimurium shows five out of ten changes in the first ten amino
acids when compared to the E. coli counterpart. These residues are
required for toxin activity28. Replacement of this region in PasTST by
the E.coli PasT sequence partially restored anti-proliferative activity
(Supplementary Fig. S2b). These results demonstrated the presence
in S. Typhimurium of an unprecedented large number of active
toxins encoded by TA modules. In addition, our data indicate that
a fewTAmodules of S.Typhimuriummight be diverging and loosing
some properties respect functional homolog alleles of closely related
bacteria.
S. Typhimurium produces inside eukaryotic cells bona fide toxins
encoded by type II TAmodules. TAmodules are in larger numbers
in pathogenic versus non-pathogenic Salmonella species (Fig. 1).
This difference led us to hypothesize that the acquisition of new
TA modules could be associated to the emergence of S. enterica as
an intracellular bacterial pathogen. Given the involvement of TA
modules in the generation of growth-arrested cells, we sought to
determine whether toxins encoded by these modules control the
capacity of S. Typhimurium to adapt to distinct intracellular
lifestyles within defined host cell types32,46. Production of com-
ponents of TA modules by intracellular S. Typhimurium was
confirmed by highly sensitive gel-free proteomics applied to
bacteria directly isolated from human fibroblasts, in which
intracellular bacteria show limited proliferation. Despite the small
size of toxin and antitoxins (average of ,100 amino acids), high-
resolution mass spectrometry identified proteins of some functional
type II TAmodules in intracellular bacteria. These include the toxins
T2ST, T4ST, T5ST, RelEST, DocST and VapC2ST and the antitoxins
A2ST, A5ST, ParDST and VapB2ST (Table 2). The same proteins
were also detected by proteomics in samples prepared from
extracellular bacteria (Table 2). This result led us to hypothesize
whether pathogen adaptation to a lifestyle of limited proliferation
inside fibroblasts is modulated by changes in the relative levels
of toxins and antitoxins encoded by TA modules. To this aim, we
generated strains bearing 3xFLAG tags in the 39 end of chromosomal
and plasmid genes encoding the toxins identified by proteomics. This
procedure was not done for the antitoxin-encoding genes as they
map upstream of toxin genes and the tagging could result in polar
effects. Western blotting assays showed that extracellular bacteria
produce rather unequal amounts of toxins T2ST, T4ST, T5ST and
VapC2ST (Fig. 3a). Noteworthy, the level of these four toxins
increases by , 4- to 13-fold in intracellular bacteria isolated from
fibroblasts (Fig. 3b). These values were obtained after correcting by
both the amount of the toxin produced by extracellular bacteria and
those of the housekeeping membrane protein IgaA detected in extra-
and intracellular bacteria (Fig. 3b). The toxin VapC2ST exhibited the
highest increase in intracellular bacteria, an observation in
concordance to the proteomic data (Table 2). Altogether, these
analyses demonstrate that inside eukaryotic cells S. Typhimurium
induces the expression of functional toxins encoded by bona fide type
II TA modules.
S. Typhimurium up-regulates inside eukaryotic cells functional
toxins encoded by type I TA modules. High-resolution mass
spectrometry did not identify toxins of type I modules in protein
extracts obtained from either extracellular or intracellular bacteria.
These toxins are small peptides of 30–50 amino acids in length,
difficult to identify even when using highly sensitive proteomic
techniques. To determine if these toxins are also produced by
intracellular S. Typhimurium, we analysed by quantitative RT-PCR
(qRT-PCR) those genes encoding toxins of type I modules that
showed anti-proliferative activity: hokST, ibsAST, ldrAST, ldrBST,
and tisBST (Fig. 2b). Intracellular bacteria isolated from human
fibroblasts up-regulate three of these genes, hokST, ldrAST and
tisBST (Fig. 3c). These data indicate that S. Typhimurium up-
regulates a selected group of type I TA modules in response to the
intracellular environment found in fibroblasts in which bacteria
undergo limited proliferation.
S. Typhimurium regulates inside eukaryotic cells the production
of toxins encoded by type II TA modules. Next, we reasoned that
the high levels of toxins encoded by type II TA modules observed in
intracellular bacteria could reflect mechanisms that ensure adaption
to an hostile environment that prevents pathogen proliferation. If
this was the case, we expected that the relative levels of toxins T2ST,
T4ST, T5ST and VapC2ST could vary if intracellular bacteria were
displaying different growth rates. This hypothesis was tested with
the 3xFLAG-tagged strains using HeLa epithelial cells, in which S.
Typhimurium proliferates massively47. Quantification of toxin levels
in actively growing bacteria isolated fromHeLa cells showed that the
amount of T4ST and T5ST toxins remain constant compared to
extracellular bacteria (Fig. 4). In the case of toxin T2ST, its
production is however down-regulated by intracellular bacteria
(Fig. 4). Of interest, levels of the pSLT plasmid-encoded toxin
VapC2ST increase notoriously (,7–14 fold) in intracellular
bacteria, irrespective of the capacity of the pathogen to proliferate
Figure 2 | Most toxins and antitoxins predicted in S. Typhimurium
SL1344 are encoded by bona fide functional TA modules. Toxin and
antitoxin genes were cloned under Plac and PBAD promoters in compatible
plasmids. These genes were expressed either independently or combined in
the natural host, i.e. S. Typhimurium strain SL1344, by plating bacteria
onto plates containing IPTG and/or arabinose. Those TA modules
highlighted in either red (type II) or orange (type I) boxes correspond to
bone fide modules. (a) type II modules; (b) type I modules. Assays were
repeated in a minimum of three independent experiments. ‘None’ means
no inducer (IPTG or arabinose) added.
www.nature.com/scientificreports
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inside the infected cell (Figs. 3b and 4). These data indicate that S.
Typhimurium regulates differently the production of some toxins
encoded by type II TA modules in varied host cell types.
Only selected groups of type I and type II TA modules impact S.
Typhimurium fitness inside eukaryotic cells. The significance of
the enhanced toxin production by S.Typhimurium inside fibroblasts
compared to epithelial cells was examined with isogenic mutants
lacking the respective toxins. We inactivated those bona fide TA
modules displaying anti-proliferative activity (Fig. 2) and that were
induced according to RT-qPCR analyses or detected by proteomics
(Table 2, Fig. 3). A total of ten toxin-defective mutants were tested in
human fibroblasts, in which S. Typhimurium show limited
proliferation. Control experiments with these toxin mutants
discarded polar effects in the genetic constructions (Supplementary
Fig. S3). None of them showed a discernable phenotype in the
invasion of the eukaryotic cell lines used (Supplementary Fig. S4)
or the growth rate inmicrobiological media (Supplementary Fig. S5).
In contrast, the absence of the three type I TAmodules tested, HokST,
TisBST and LdrAST, or the toxins T4ST andVapC2ST, encoded by type
II TA modules, impacted negatively the survival of intracellular
bacteria inside fibroblasts (Fig. 5a). These toxins were also required
for survival of intracellular bacteria in the unrelated rat fibroblast cell
line NRK-49F (Supplementary Fig. S6). The DvapC2ST mutant
displayed the strongest phenotype with a decrease of up to ,80%
in the intracellular survival rate compared to wild-type bacteria
(Fig. 5a and Supplementary Fig. S6).
We further tested a multiple mutant lacking the five toxins
required for survival of intracellular bacteria (Dhok-sokST DtisB-
istRST DldrA-ldrAST Dta4ST DvapBC2ST). This mutant showed a
phenotype undistinguishable from individual mutants (Fig. 5a).
These data indicate that this set of toxins could be acting in a coor-
dinated manner to prepare bacteria to cope with host defences.
Alternatively, some of these toxins might operate in similar if not
identical targets or processes, explaining why we did not observe
additive effects. Noteworthy, when the same set of mutants was
tested in HeLa epithelial cells, only the DvapC2ST mutant and the
quintuple mutant showed a clear phenotype. These two mutants
proliferate intracellularly with lower growth rates than wild-type
bacteria (Fig. 5b). Taken together, these results differentiated toxins
of TA modules that impact positively the fitness of intracellular
bacteria showing limited proliferation (case of HokST, TisBST,
LdrAST, and T4ST) from other toxins such as VapC2ST, required
for fitness of S. Typhimurium inside the host cell irrespective of
the growth rate.
Discussion
The data reported here increase significantly the current list of TA
modules known for S.Typhimurium and provide experimental evid-
ence for a vast number of bona fide TA modules, more than those
recently characterized or predicted in databases9,31,32,48.We identified
27 TA modules and 20 toxins encoded by these modules have anti-
proliferative activity in its natural host, S. Typhimurium. This vast
repertoire of ‘functional’ toxins, which includes members of type I
and type II modules, contrasts with the only four functional toxins
recognized by De la Cruz et al. based on diminished growth rate
when overexpressed in E. coli31. The proportion of functional toxins
characterized here in S. Typhimurium is also higher than the
reported for M. tuberculosis, in which 30 of the 88 predicted and
individually-tested TA modules were proved to be functional8.
Our study also uncovered apparent ‘non-functional’ TA modules.
Seven toxin candidates did not affect S. Typhimurium growth (T3ST,
Table 2 | Toxins and antitoxins of S. Typhimurium TA modules detected by mass spectrometry in bacteria isolated from fibroblasts and in
bacteria grown in LB medium
Extracellular ({) Intracellular ({)
Accesion Number Protein (*) Mass (Da) Unique peptides PSMs Coverage (%) Unique peptides PSMs Coverage (%)
SL1479 RelEST 11,070 3 8 29.79 1 4 9.57
SL1480 RelBST 9,086 1 2 23.17 - - -
SL2379 A1ST 13,536 4 19 33.33 - - -
SL2380 T1ST 14,966 4 6 34.62 - - -
SL2658 PasIST 10,769 3 6 31.25 - - -
SL2659 PasTST 17,725 2 3 13.29 - - -
SL2884 A2ST 10,673 2 5 28.13 2 2 31.25
SL2885 T2ST 19,059 2 4 13.14 2 4 20.00
SL2936 ParDST 10,369 - - - 1 1 7.69
SL3011 VapCST 14,930 - - - 1 1 21.21
SL3012 VapBST 14,276 2 3 13.60 1 2 6.40
SL3437 T3ST 22,767 11 27 68.00 8 27 47.00
SL3484 DinJST 9,442 2 4 24.42 - - -
SL3524 DocST 13,580 1 2 7.38 1 2 10.66
SL3617 T4ST 17,693 2 5 22.36 1 3 8.07
SL3744 RelB3ST 11,754 4 6 36.45 - - -
SL3976 SehBST 15,915 1 2 7.75 - - -
SL3979 SehCST 12,326 1 1 8.33 - - -
SL4253 A5ST 10,972 1 2 9.28 2 4 23.71
SL4254 T5ST 17,636 1 1 7.98 1 6 7.98
SL4460 ShpBST 11,368 2 3 39.00 - - -
SL4459 ShpAST 11,289 2 2 22.11 - - -
SLP2_0003 RelB4 10,176 1 1 7.87 - - -
SLP2_0004 RelE4ST 10,888 1 4 15.05 - - -
PSLT028 CcdBST 11,581 3 13 40.59 3 8 40.59
PSLT107 VapB2ST 8,636 1 2 10.53 2 3 22.37
PSLT106 VapC2ST 14,879 2 6 21.21 3 7 29.55
(*) Subscript ST is added for clarification purposes to refer exclusively to TA protein characterized functionally in S. Typhimurium (see Fig. 2). Toxins are underlined.
({) Protein extracts prepared from bacteria grown in LB medium to stationary phase at 37uC in non-shaking conditions. Two independent experiments were performed. PSM, peptide spectrum match.
({) Protein extracts were prepared from non-growing intracellular bacteria at 24 h post-infection of BJ5ta human fibroblasts. Three independent experiments were performed. PSM, peptide spectrum match.
www.nature.com/scientificreports
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CcdBST, HigBST, PasTST, VapCST, IbsBST and SymEST). Additionally,
two putative type II antitoxins did not neutralize their cognate toxins
partners (A1ST and RelB3ST). We confirmed that these proteins were
efficiently produced from the respective plasmids, so other factors
should explain such negative outcome. For CcdBST and PasTST,
which have active orthologs in E. coli, site-directed mutagenesis
showed that discrete differences in sequence compromise activity
in S. Typhimurium. This was an unexpected finding that opens
new questions regarding the evolution and deterioration (or special-
ization to other yet unknown functions) of certain TA modules in
otherwise rather genetically close bacteria. Lastly, the possibility that
a chromosomally-encoded antitoxin could counteract plasmid-
encoded toxin cannot be discarded. However, this case seems
unlikely given the marked difference in the stability and stoichi-
ometry of the two components. For the ‘inactive antitoxins’ A1ST
and RelB3ST, a possible alternative is that other components are
needed for proper antitoxin function, as it was shown for the HigA
antitoxin of M. tuberculosis49. These two proteins could also not
correspond to true antitoxins even considering they map in prox-
imity to the toxin gene. A precedent exists in themazEF TA module
of Myxococcus xanthus, in which antitoxin and toxin genes map
apart one from the other50.
To our knowledge, the activity of defined TA modules in control-
ling growth of an intracellular pathogen inside non-phagocytic host
cell types was not investigated at the cellular level before this study.
The data obtained in fibroblasts uncover a selected class of type I and
type II TAmodules (HokST, TisBST, LdrAST, T4ST andVapC2ST) that
are required for S. Typhimurium to survive within this host cell type.
Our data provide new information with respect to the recent study of
Helaine et al., which analysed type II TA modules in the S.
Typhimurium-macrophage infection model32. First, we demonstrate
that toxins encoded by type I TA modules are also as important as
those of type II TA modules for the fitness of intracellular S.
Typhimurium. Second, unlike the work of Helaine et al., which
Figure 3 | S. Typhimurium up-regulates inside fibroblasts bona fide toxins encoded by type I and type II TA modules. S. Typhimurium was
chromosomally tagged with 3xFLAG epitope in genes encoding toxins of type II TA modules detected by proteomics (see Table 2). Protein extracts were
prepared from intracellular bacteria at 24 h post-infection of BJ5ta human fibroblasts and extracellular bacteria grown to stationary phase in LBmedium.
(a) toxins of type II modules detected in extracellular bacteria. Note the distinct relative levels of the toxins examined; (b) synthesis of toxins of type II
modules in intracellular bacteria. Note that the four toxins shown (T2ST, T4ST, T5ST, and VapC2ST) are produced at higher relative levels inside the
eukaryotic cells. The inner membrane IgaA was used as loading control. Numbers below the toxin bands correspond to the relative values determined by
densitometry, referred to values measured in extracellular bacteria and corrected by those obtained for the loading control, the IgaA protein;
(c) quantitative RT-PCR (qRT-PCR) assays showing the relative expression of five genes encoding toxins of type II modules. Note that three of them
displayed significant induction in intracellular bacteria. Data are the means and standard deviations from three independent experiments. *, P5 0.01 to
0.05; **, P 5 0.01 to 0.001, by one-way ANOVA with Dunnett’s post-test.
Figure 4 | Up-regulation of toxins encoded by type II modules by
S. Typhimurium is restricted to VapC2ST when growing inside HeLa
epithelial cells. 3xFLAG-tagged S. Typhimurium strains were used to
infect human HeLa epithelial cells for 16 h. At this time, protein extracts
were prepared from intracellular bacteria and tested for toxin protein by
Western blotting assay. Numbers below the toxin bands correspond to the
relative values determined by densitometry, referred to values measured in
extracellular bacteria and corrected by those obtained for the loading
control, the IgaA protein. Note that among the four toxins tested only
VapC2ST is produced by bacteria at higher relative levels inside the
eukaryotic cells. The Western blots shown are representative of a total of
three independent experiments.
www.nature.com/scientificreports
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implicated all type II TA modules that they tested (14 modules) in
persister cell formation inside macrophages32, our data support a
clear specialization of functions among distinct type II TA modules.
Differences in the host cell type that is invaded by the pathogenmight
dictate a critical function for distinct sets of TA modules. Thus,
among the type II TA modules tested, only the toxins VapC2ST
and T4ST impact fitness of S. Typhimurium inside fibroblasts.
VapC2ST is predicted to have RNAse activity due to the functional
domain conservationwith its paralog toxinVapCST51, which behaved
as a ‘non-functional’ toxin in our assays (Fig. 2). Regarding T4ST, a
novel toxin encoded by a TAmodule discovered in this study, it bears
a Gcn5-related acetyl transferase (GNAT) domain. This domain is
present in members of a protein superfamily that utilizes acyl coen-
zyme A (CoA) as donor for the acylation of lysine residues52. These
enzymes have a large variety of substrates, from nascent endogenous
proteins to histones or antibiotics53. In S.Typhimurium, the action of
a GNAT domain-containing protein termed Pat has been related to
the control of carbon utilization andmetabolic flux via acetylation of
several metabolic enzymes54. The decreased survival inside fibro-
blasts experienced by themutant lacking T4ST supports an important
role of metabolic readjustment(s) in ensuring the fitness of intracel-
lular S. Typhimurium under conditions of limited growth. This
assumption agrees with genome-wide profiling data obtained in this
pathogen under identical infection conditions41, which showed up-
regulation of metabolic genes involved in adaptation to microaero-
philic conditions.
TisBST, LdrAST and HokST form the subset of toxins encoded
by type I TA modules important for fitness of intracellular S.
Typhimurium. In E. coli these three toxins have been related to
dissipation of transmembrane potential and ATP depletion55–57. A
‘controlled’ action of these toxins in intracellular bacteria could
potentially assist S. Typhimurium for acquiring the required state
of metabolic dormancy in fibroblasts. This model fits with the
increased expression of genes encoding Phage-shock proteins
(Psp) observed in intracellular S. Typhimurium41,58. The bacterial
response involving Psp proteins is triggered as a consequence of
stress reducing the energy status of the cell. It is tempting to hypo-
thesize about these Psp proteins as elements balancing the limited
damage induced by the toxins encoded by TA modules. This idea
could be evaluated in future studies.
Among the five toxins that ensure S. Typhimurium fitness inside
fibroblasts, LdrAST, HokST, and VapC2ST are absent in the non-
pathogenic species S. bongori. HokST and VapC2ST are encoded by
plasmids that are absent in S. bongori, however LdrAST is encoded by
a chromosomal gene. Noteworthy, ldrAST is conserved in all S. enter-
ica serovars (Fig. 1), which suggests that acquisition of this particular
TAmodulemight be occurred during the evolution and speciation of
S. enterica as pathogen. Another conclusion of our study involves the
different toxins encoded by TA modules that ensure fitness of intra-
cellular S. Typhimurium in distinct host cell types. Thus, the beha-
viour of actively growing S. Typhimurium located HeLa epithelial
cells is altered exclusively in the absence of the VapC2ST toxin. This is
an interesting observation since all toxins tested were shown by
Western blotting to be produced by intracellular S. Typhimurium
in both fibroblasts and epithelial cells, although at varied relative
amounts. Based on these findings, not only the type of toxins but
also the proportion at which are produced by the pathogen inside the
eukaryotic cell might balance the final outcome in terms of persist-
ence or active proliferation. This assumption also considers the
importance that the coordination among members of such ‘toxin-
cocktail’ might have. Lack of a particular toxin in such specialized
group could lead to de-regulation of the rest and, as a consequence, to
a negative impact on the fitness of intracellular bacteria. This
assumption is consistent with two recent studies that demonstrate
cross-regulation among distinct TA modules of E.coli59,60.
Intracellular S. Typhimurium is exposed within the phagosome to
stresses like acidic pH, oxidative and nitrosative reactive molecules
and, high osmolarity61. This fact could explain the apparent higher
content of TA modules in bacterial pathogens that infect eukaryotic
cells compared to environmental bacteria. Nonetheless, we did not
Figure 5 | Distinct type I and type II TA modules impact fitness of intracellular S. Typhimurium in fibroblasts and epithelial cells. Shown are the
survival rates of S. Typhimurium mutants lacking the indicated type I (grey bars) and type II (white bars) TA modules. (a) ratio of viable intracellular
bacteria at 24 h and 2 h post-infection in human BJ5ta fibroblasts; (b) ratio of viable intracellular bacteria at 16 h and 2 h post-infection in humanHeLa
epithelial cells. ‘‘D5’’ refers to the Dhok-sokST DtisB-istRST DldrA-ldrAST Dta4ST DvapBC2ST mutant. Data are the means and standard deviations from
three independent experiments. *, P 5 0.01 to 0.05; **, P 5 0.01 to 0.001; ***, P 5 , 0.001, by one-way ANOVA with Dunnett’s post-test.
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observe any additive effect following the absence of all those toxins of
type I and type II modules that impact positively the fitness of intra-
cellular bacteria. This finding could be in concordance with the
model supporting a coordinated action of distinct toxin groups.
The loss of this hypothetical coordination due the absence of a par-
ticular toxin might not change in quantitative terms when additional
toxins are lacking. Precedents for this phenomenon exist in the lit-
erature. Thus, the two VapBC TAmodules encoded byH. influenzae
contribute to virulence29. However, the phenotype of a double
mutant lacking both VapBCmodules is indistinguishable from those
of the individual mutants.
In summary, the data shown here support a marked specialization
of defined TA modules for regulating the intracellular lifestyle of
bacterial pathogens. These TA modules would be involved in ensur-
ing pathogen intracellular survival, which is critical for the progres-
sion of the infection. It is also worthy to note that, to our knowledge,
the data shown here implicate for the first time two plasmid-encoded
TA modules, hok-sokST and vapBC2ST, in infection. Of interest in
future studies will be also to characterize the regulators that alter the
relative levels of toxins encoded by some of these TA modules when
the pathogen resides inside the eukaryotic cell.
Methods
Bacterial strains and plasmids used in this study. The S. enterica serovar
Typhimurium and E. coli strains together with plasmids used in this study are listed in
Supplementary Table S3.
Identification of TA modules in S. Typhimurium SL1344. Complete nucleotide
sequences of the S. Typhimurium SL1344 chromosome and the three plasmids
carried by this strain were downloaded from NCBI. The respective entries are:
NC_016810.1 (chromosome), NC_017720.1 (plasmid 1, pSLT), and NC_017718.1
(plasmid 2, pCol1B9) and NC_017719.1 (plasmid 3, pRSF1010). A total of 27 TA
modules were identified (information compiled in Supplementary Table S1). The
TADB resource (http://bioinfo-mml.sjtu.edu.cn/TADB/)9 and the catalogue
published by Fozo et al.7, were used to identify type II and type I TA modules,
respectively. In the case of the TADB resource, the WU-BLAST 2.0 tool was selected.
To upload genome sequences into these resources in an operative manner, the
S. Typhimurium SL1344 chromosomal sequence was divided in four sections. Three
inter-fragment sequences were created to detect possible operons overlapping
borders between fragments of consecutive fragments. Plasmids sequences were
uploaded un-fragmented. BLOSUM62 was selected as comparison matrix, default
parameters for cut-off score and word length, and an e-value of 0.01. To avoid
spurious hits, searches were manually cured. Thus, hits were discarded when having
more than 650 bp in length, not forming part of an operon (establishing a maximum
distance of 150 bp between toxin and antitoxin genes), or previously characterized as
genes non-related to TAmodules. In a second survey, several already identified toxin
and antitoxin sequences (including TAmodules of type I, II, III, IV and V) were used
as queries to a PSI-BLAST search against genome of S. Typhimurium SL1344
(Supplementary Table S2). PSI-BLAST was executed as previously described62.
Cloning of S. Typhimurium toxin and antitoxin genes. The expression vectors
pACYC18463 and pFUS264 were used to clone and express toxin and antitoxin genes
with the following modifications. A Plac promoter was obtained from plasmid
pNDM22065 as a ZraI/BamHI restriction fragment and introduced in the BamHI site
of pACYC184. An optimized Shine-Dalgarno sequence66 and a polylinker containing
ZraI/SpeI restriction sites (between BamHI and SalI sites), were also introduced.
Additionally, lacIQ repressor was cloned between PsiI/EcoRV sites to ensure proper
transcription control. The same Shine-Dalgarno and polylinker were cloned behind
the PBAD promoter of plasmid pFUS2, between EcoRI and KpnI restriction sites.
Candidate toxin and antitoxin genes were cloned in either pACYC184- or pFUS2-
based expression vectors. Toxin and antitoxin genes were amplified using Pfu
polymerase (Promega) using S. Typhimurium genomic DNA as template and
primers containing ZraI/SpeI restriction sites (Supplementary Table S4). The
fragments were ligated (T4 DNA ligase, Promega) 30 min at room temperature
(24uC) and transformed in S. Typhimurium SL1344 competent cells. All inserts were
sequenced to verify a correct construction of the recombinant plasmid.
Construction of S.Typhimuriummutants defective in TAmodules. For disruption
of toxin-antitoxin genes, the deletion method described by Maisonneuve et al.67, was
followed.
Construction of S. Typhimurium recombinant strains expressing 3x-FLAG-
tagged toxins. 3x-FLAG tagging was performed at the 39-end of toxin genes in their
respective chromosomal or plasmidic locations using the procedure of Uzzau et al.68.
Oligonucleotide primers used in these procedures are listed in Supplementary Table
S4.
Functional assays to detect toxin and antitoxin activities. Toxicity and
neutralization assays were developed based on expression of toxin and antitoxin
proteins from the compatible vectors pACYC184 and pFUS2 bearing Plac or PBAD
promoters, respectively. Induction of the desirable protein was carried out with IPTG
(isopropyl b-D-1-thiogalactopyranoside) or arabinose.Most toxins were expressed in
pFUS2 and its cognate antitoxins in pACYC184. Corresponding pair components of
TA modules were co-expressed in S. Typhimurium SL1344. Bacteria were grown
overnight in LBmedium containing the corresponding antibiotic for each vector and
supplemented with 0.4% glucose for those cases in which the toxin gene was cloned in
pFUS2. This culture was diluted 15100 in fresh LBmedium and bacteria grown up to
an optical density (OD600) of 0.3. At this time, serial dilutions made in phosphate
buffered saline (PBS) pH 7.0 were plated onto solid media containing toxin and
antitoxin inducers (IPTG and/or arabinose). IPTG and arabinose concentrations
were adjusted to optimize visualization of toxin and antitoxin activities.
Distribution of TAmodules among Salmonella species and serovars.To determine
the phylogenetic distribution of the 27 TA modules identified in S. Typhimurium
SL1344, we first examined the comparative genomic study recently reported by
Nuccio and Ba¨umler44. This study analyzed 17 genomes of different S. enterica
serovars mostly associated to intestinal or extraintestinal infections. In addition,
TBLASTN was used: i) to determine the distribution of those TA modules identified
in our study that were not listed in the Nuccio and Ba¨umler compilation; and, ii) to
compare the distribution of all 27 identified TA modules in S. Typhimurium strain
SL1344 with those present two strains of the non-pathogenic species S. bongoriwhose
genome sequence is available (strains N268-08 and NCTC12419). For TBLASTN,
only hits with e-values of # 1025 with a length of 30 amino acids or over were
considered significant.
Bacterial infection of fibroblasts and epithelial cells. Foreskin human BJ-5ta
fibroblasts (ATCC CRL-4001) and HeLa epithelial cells (ATCC CCL-2) were used.
These two cell lines were propagated and infected as described69. Number of viable
intracellular bacteria was determined by plating (in triplicate) serial dilutions of the
cell lysate at the different post-infection times. Proliferation index was calculated as
the ratio of colony forming units (cfu) counted at 24 h (fibroblasts) or 16 h (epithelial
cells) versus 2 h post-infection. Assays were performed in a minimum of three
independent repetitions.
Isolation of intracellular bacteria for proteomic and Western analyses. Protocols
optimized for the isolation of intracellular S. Typhimurium from infected fibroblasts
to obtain bacterial RNA and protein have been described elsewhere41,46. These large-
scale infections were designed with aminimum of 12 BioDish-XL 500-cm2 plates (ref.
351040, BD Biosciences) per bacterial strain and post-infection time.
Toxin/antitoxin expression in intracellular bacteria monitored by Western
immunoblot. Isogenic S. Typhimurium strains carrying a 3xFLAG tag in defined
chromosomal toxin genes were constructed (Supplementary Table S3). These tagged
strains were used to infect human BJ-5ta fibroblasts or HeLa epithelial as described69.
Protein extracts prepared from intracellular bacteria were resolved in SDS-PAGE
using 10%polyacrylamide gels and processed forWestern blot assays with anti-FLAG
antibody (ref. F3165, Sigma-Aldrich). Levels of the S. Typhimurium inner membrane
protein IgaA were monitored as loading control.
Proteomic analysis in extra- and intracellular bacteria. Proteome comparison was
performed in bacteria grown overnight in LB medium at 37uC and intracellular
bacteria collected at 24 h post-infection from human BJ-5ta fibroblasts. Protein
extracts were prepared as described41,46, run in SDS-PAGE using 15% acrylamide gels
and stained with ‘Colloidal blue staining kit’ (Invitrogen). These extracts were
prepared as three biological replicates for intracellular bacteria and two replicates for
extracellular bacteria grown to stationary phase. Samples were run by SDS-PAGE,
stained and collected as 1-mm width gel slices. These slices were cut in eight pieces,
washed in 50 mM ammonium bicarbonate and 50% acetonitrile (ACN) and
dehydrated with ACN (100%). Gel pieces were rehydrated in 50 mM ammonium
bicarbonate with 12.5 ng/ml trypsin and incubated overnight at 30uC. Tryptic
peptides were extracted at 37uC using ACN 100% and 0.5% trifluoroacetic acid
(TFA), dried, cleaned using ZipTip (Millipore) and reconstituted in 5 ml 0.1% formic
acid/2% ACN. This peptide mix was loaded into a C18-A1 ASY-Column 2 cm
precolumn (Thermo Scientific EASY-Column), eluted with a Biosphere C18 column
(75 mm inner diameter, 15 cm long, 3 mm particle size) (NanoSeparations), and
finally separated using a 150 min gradient with the last 100 min from2–35% buffer B.
Composition of buffer A was: 0.1% formic acid/2% ACN and that of buffer B: 0.1%
formic acid in ACN. Flow-rate was 250 nL/min on a nano EASY-nLC (Thermo
Scientific) coupled to a nanoelectrospay ion source (Thermo Scientific). Mass spectra
were acquired on the LTQ-Orbitrap Velos (Thermo Scientific, San Jose, CA) in the
positive ion mode. Full-scan MS spectra (m/z 300-2000) were acquired in the
Orbitrap with a target value of 1,000,000 at a resolution of 30,000 at m/z 400. For
internal mass calibration, the 445.120025 ion for lock mass was used. Charge state
screening was enabled and precursors with charge state unknown or 1 were excluded.
After the survey scan, the tenmost intense precursor ions were selected for CID-HCD
MS/MS fragmentation. Peptide identification was performed in both CID (Collision
Induced Dissociation) and HCD (Higher-Energy Collision Induced Dissociation)
spectra. For CID fragmentation the target value was set to 10,000 and normalized
collision energy to 35%. For HCD, target value was set to 50,000 and collision energy
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was set to 45%. Dynamic exclusion was applied during 30 s. MS data were analyzed
with Proteome Discoverer (version 1.3.0.339) (Thermo Fisher, San Jose, CA) using
standardized workflows with Sequest search engine. MS/MS spectra were searched
against an in-house created FASTA database with the sequences of the toxin and
antitoxin protein identified in silico in S. Typhimurium strain SL1344 (Table 1,
Supplementary Table S1). Search parameters included a maximum of two missed
cleavages allowed, carbamidomethylation of cysteines as a fixed modification, and
oxidation of methionine as variable modifications. Precursor and fragment mass
tolerance were set to 10 ppmand 0.8 Da, respectively. Identified peptides were filtered
by false discovery rate of 0.01 using Percolator.
Real-time quantitative PCR. Large scale infection of human BJ-5ta fibroblasts was
performed as described41. Total RNA (prokaryotic and eukaryotic RNA) was isolated
by addition of 1 ml of Trizol reagent (Invitrogen) following indications of
manufacturer and co-precipitated with 20 mg of glycogen (Roche). RNA samples
were treated with DNAseI for 1 hour at 37uC (Turbo DNA-free kit Ambion/Applied
Biosystems). cDNA libraries were constructed from 1 or 2 mg of RNA obtained from
extracellular or intracellular bacteria, respectively (High-capacity cDNA archive kit,
Applied Biosystems). For qPCR, the Power Sybr Green PCR master mix (Applied
Biosystems) was used in a 10 ml final volume and reactions were carried out in an ABI
Prism 7500 equipment following standard reaction conditions according to
manufacturer’s recommendations. Each cDNA sample was run in triplicate and
expression data from each condition were obtained from three independent
experiments.
Statistical analyses and densitometry. Statistical significance was analyzed with
GraphPad Prism v5.0b software (GraphPad Inc.,) using one-way analysis of variance
(ANOVA) with Dunnett’s multiple comparison post-test. A P value # 0.05 was
considered significant. Densitometry on toxins bands obtained in the Western
blotting assays was performed using ImageJ, made available to the public by National
Institute of Health, USA.
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